Damir Vrbanec
- Co-authors
- Jasminka Jakić‐RazumovićBranka PetričevićMaja Sirotković-SkerlevZsuzsanna KahánJasminka PavelićJelena KneževićJozef MardiakGodfrey E. Etokebe
- Topics
- HER2/EGFR in Cancer Research (5 papers)Cancer Treatment and Pharmacology (5 papers)Breast Cancer Treatment Studies (5 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología
In The Last Decade
Damir Vrbanec
44 papers receiving 469 citations
Peers
Comparison fields: 5 of 88
- Oncology 269
- Molecular Biology 129
- Cancer Research 127
- Immunology 91
- Pulmonary and Respiratory Medicine 69
Countries citing papers authored by Damir Vrbanec
This map shows the geographic impact of Damir Vrbanec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damir Vrbanec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damir Vrbanec more than expected).
Fields of papers citing papers by Damir Vrbanec
This network shows the impact of papers produced by Damir Vrbanec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damir Vrbanec. The network helps show where Damir Vrbanec may publish in the future.
Co-authorship network of co-authors of Damir Vrbanec
This figure shows the co-authorship network connecting the top 25 collaborators of Damir Vrbanec. A scholar is included among the top collaborators of Damir Vrbanec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damir Vrbanec. Damir Vrbanec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | Characteristics and Prognosis of Triple-Negative Breast Cancer Patients: a Croatian Single Institution Retrospective Cohort Study | 1 |
| 5 | [CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES Part V: melanoma, sarcomas, central nerve system tumors, lung cancer]. | 2 |
| 6 | CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part I: breast cancer, uterine cancer, cervical cancer, ovarian cancer. | 1 |
| 7 | 10 | |
| 8 | 1 | |
| 9 | [CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP OF PATIENTS WITH MELANOMA]. | 2 |
| 10 | 21 | |
| 11 | Sirtuins in tumorigenesis | 3 |
| 12 | 7 | |
| 13 | 14 | |
| 14 | 2 | |
| 15 | 20 | |
| 16 | 15 | |
| 17 | Role of HER2 signaling pathway in breast cancer: biology, detection and therapeutical implications | 8 |
| 18 | 5 | |
| 19 | 45 | |
| 20 | 17 |
About Damir Vrbanec
Damir Vrbanec is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 45 papers that have together received 486 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (5 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Oncology (269 citations), Cancer Research (127 citations) and Immunology (91 citations). Damir Vrbanec has collaborated with scholars based in Croatia, Austria and Romania. Frequent co-authors include Jasminka Jakić‐Razumović, Branka Petričević, Maja Sirotković-Skerlev, Zsuzsanna Kahán, Jasminka Pavelić, Jelena Knežević, Jozef Mardiak, Godfrey E. Etokebe, Zlatko Dembić and J. Eglītis. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.